Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsGraft vs Host DiseaseBusulfanHematopoietic Stem CellsTreatment OutcomeGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCord Blood Stem Cell TransplantationCytarabineHodgkin DiseaseDisease-Free SurvivalTissue DonorsTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisInfectionLymphoma, T-CellHistocompatibilityDoxorubicinImmunosuppressive AgentsPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinTransplantation, IsogeneicLeukemia, Myeloid, AcuteVidarabineDexamethasoneFollow-Up StudiesBlood Cell CountLeukemiaRecombinant ProteinsCytomegalovirus InfectionsAntineoplastic AgentsBone Marrow PurgingEmbryonic Stem CellsBlood CellsProspective StudiesLymphomaGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAdult Stem CellsMesenchymal Stem Cell TransplantationMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousLymphocyte DepletionLiver TransplantationCyclosporineT-LymphocytesOpportunistic InfectionsBone MarrowHematologic DiseasesCell SeparationImmunosuppressionLeukocytes, MononuclearHLA AntigensPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma